Daniel Pella, M.D., Ph.D.
Professor Daniel Pella finished his medicine studies at Pavol Jozef Safarik University (UPJS) in Kosice, Slovakia in 1986. Defended his Ph.D. thesis in Internal Medicine in 2000, gained postgraduate specializations in Internal Medicine and Cardiology in 1989 and 1995, respectivelly. He was appointed Professor of Medicine at Charles University in Prague in 2007.
His professional career is dedicated maily to preventive and non-interventional cardiology. He was founder and the first Head of Centre of Preventive and Sports Medicine at L. Pasteur University Hospital and Faculty of Medicine UPJS in Kosice in 2006. Later on, this centre became an integrative part of the 3rd Department of Medicine, where he was again nominated for the Head of the Department. He developed there with help of
the European Union Structural Funds Centre of Excellency for Atherosclerosis Research. He was appointed head of the 2nd Cardiology Dpt. In Eastern Slovak Institute for Cardiovascular Disease in Kosice from September 2018.
He is Executive Director of the International College of Cardiology, Past-President of the International College of Nutrition and President of Slovak Association of Atherosclerosis.
Professor Daniel Pella is representative of Slovak Republic and Head of ERIC-ECRIN chapter SLOVACRIN.
He is chairman of the Scientific Board of PJ Safarik University Faculty of Medicine and member of severalother scientific boards including Scientific Board of Slovak Ministry of Health.
During period from 2010-2014 he was Vice-Dean for International Relations at Faculty of Medicine UPJS and in October 2014 was elected for Dean of this Faculty for period 2014-2018.
During his career delivered more than 500 lectures in Slovakia and abroad, many of them were invited ones. Published more than 150 articles, large part of them indexed in Current Contents and his articcles were cited more than 600 times in databases Web of Science and Scopus. He is member of Editorial Boards of several national and international journals and member of Steering Committees and National Coordinator of several multicentre randomized clinical trials.